|
| MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infection |
|
https://doi.org/10.18632/oncotarget.27799
Lanlan Zhou, Kelsey Huntington, Shengliang Zhang, Lindsey Carlsen, Eui-Young So, Cassandra Parker, Ilyas Sahin, Howard Safran, Suchitra Kamle, Chang-Min Lee, Chun Geun Lee, Jack A. Elias, Kerry S. Campbell, Mandar T. Naik, Walter J. Atwood, Emile Youssef, Jonathan A. Pachter, Arunasalam Navaraj, Attila A. Seyhan, Olin Liang, Wafik S. El-Deiry
|
| 4201-4223 |
|
| Identification of Mubritinib (TAK 165) as an inhibitor of KSHV driven primary effusion lymphoma via disruption of mitochondrial OXPHOS metabolism |
|
https://doi.org/10.18632/oncotarget.27815
Abram Calderon, Samantha S. Soldan, Alessandra De Leo, Zhong Deng, Drew M. Frase, Emma M. Anderson, Yue Zhang, Olga Vladimirova, Fang Lu, Jessica C. Leung, Maureen E. Murphy, Paul M. Lieberman
|
| 4224-4242 |
|
| Evidence for context-dependent functions of KDM5B in prostate development and prostate cancer |
|
https://doi.org/10.18632/oncotarget.27818
Bigang Liu, Rahul Kumar, Hseuh-Ping Chao, Rashid Mehmood, Yibing Ji, Amanda Tracz, Dean G. Tang
|
| 4243-4252 |
|
| Immune profiling of the bone marrow microenvironment in patients with high-risk localized prostate cancer |
|
https://doi.org/10.18632/oncotarget.27817
Erika Heninger, Nan Sethakorn, David Kosoff, Peiman Hematti, Morgan D. Kuczler, Kenneth J. Pienta, Joshua M. Lang
|
| 4253-4265 |
|
| Auto-antibodies against apolipoprotein A-1 block cancer cells proliferation and induce apoptosis |
|
https://doi.org/10.18632/oncotarget.27814
Nathalie Satta, Rémy Weppe, Sabrina Pagano, Miguel Frias, Catherine Juillard, Nicolas Vuilleumier
|
| 4266-4280 |
|
| Phase I dose escalation study of 12b80 (hydroxybisphosphonate linked doxorubicin) in naturally occurring osteosarcoma |
|
https://doi.org/10.18632/oncotarget.27801
Pierre Boyé, Emmanuelle David, François Serres, Quentin Pascal, Franck Floch, Kévyn Geeraert, Virginie Coste, Laurent Marescaux, Sébastien Cagnol, Jean-Yves Goujon, Maxim Egorov, Ronan Le Bot, Dominique Tierny
|
| 4281-4292 |
|
| Identification of novel prognostic markers of survival time in high-risk neuroblastoma using gene expression profiles |
|
https://doi.org/10.18632/oncotarget.27808
Abdulazeez Giwa, Azeez Fatai, Junaid Gamieldien, Alan Christoffels, Hocine Bendou
|
| 4293-4305 |
|
| MicroRNA-based regulation of Aurora A kinase in breast cancer |
|
https://doi.org/10.18632/oncotarget.27811
Adewale Oluwaseun Fadaka, Nicole Remaliah Samantha Sibuyi, Abram Madimabe Madiehe, Mervin Meyer
|
| 4306-4324 |
|
| Intracellular hyaluronic acid-binding protein 4 (HABP4): a candidate tumor suppressor in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.27804
Talita Diniz Melo-Hanchuk, Carolina Colleti, Ângela Saito, Maria Carolina Santos Mendes, José Barreto Campello Carvalheira, Jose Vassallo, Jörg Kobarg
|
| 4325-4337 |
|
| HER2 splice variants in breast cancer: investigating their impact on diagnosis and treatment outcomes |
|
https://doi.org/10.18632/oncotarget.27789
Vic Hart, Hannah Gautrey, John Kirby, Alison Tyson-Capper
|
| 4338-4357 |
|
| A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer |
|
https://doi.org/10.18632/oncotarget.27809
Sewanti Limaye, Prashant Kumar, Ramya Pragya, Janani Sambath, Darshana Patil, Ajay Srinivasan, Sachin Apurva, Navin Srivastava, Sanket Patil, Revati Patil, Vineet Datta, Dadasaheb Akolkar, Rajan Datar
|
| 4358-4363 |
|
| Correction: Quinacrine inhibits GSTA1 activity and induces apoptosis through G1/S arrest and generation of ROS in human non-small cell lung cancer cell lines |
|
https://doi.org/10.18632/oncotarget.27821
Makhan Kumar, Ansie Martin, Snehal Nirgude, Bibha Chaudhary, Sukanta Mondal, Angshuman Sarkar
|
| 4364-4365 |
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
